Oruka Therapeutics

IPO

A new era for chronic skin diseases

Public · Menlo Park, United States · Founded 2024 · $205.0M raised

Employees
11–50
Founded
2024
Business Model
B2B
Total Funding
$205.0M
Last Round
$180.0M Private EquitySep 2025
Rounds
2
Type
Public

About

Oruka Therapeutics is a clinical-stage biopharmaceutical company developing novel monoclonal antibodies designed to set a new standard for the treatment of chronic skin diseases. The company is advancing potentially best-in-class biologics — ORKA-001 and ORKA-002 — that aim to deliver higher rates of complete disease clearance in moderate-to-severe plaque psoriasis with as few as one or two doses per year. Founded by seasoned biopharma professionals, Oruka's name reflects its mission: derived from 'or' for 'skin' and 'arukah' for 'restoration.'

Summary

Oruka Therapeutics is a Healthcare company based in Menlo Park, United States, founded in 2024. It has raised $205.0M in total across 2 rounds, most recently a $180.0M Private Equity round in Sep 2025. Investors include Viking Global, Fairmount Funds and Blackstone.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOApr 2026
$700.0M

Sign up to see all 3 rounds

Convertible Note through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Oruka Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/oruka-therapeutics"><img src="https://indexed.vc/api/badge/company/oruka-therapeutics" alt="Oruka Therapeutics on Indexed.vc" width="260" height="76" /></a>